EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

A Randomized, Open‐Label, Single‐Dose, Parallel‐Group Bioequivalence Study of Ferric Carboxymaltose Injection Under Fasting Conditions in Chinese Adult Subjects With Iron Deficiency Anemia

Fengyun Gong, Shengling Hu iD, Jiandong Yuan, Jianxin Song

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70137 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Fengyun Gong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Phase I Clinical Trial, Laboratory, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Clinical…. Hauptthemen laut MEDLINE: Maltose, Anemia, Iron-Deficiency, Ferric Compounds, Hematinics. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objectives of this study were to compare the pharmacokinetics and safety profiles of the test (T) preparation (Ferric carboxymaltose injection, BrightGene Bio‐Medical Technology Co. Ltd.) and reference (R) preparation (Ferinject, Vifor France) after intravenous injection in Chinese adult subjects with iron deficiency anemia (IDA) under fasting conditions. Conducted as a single‐center, randomized, open‐label, parallel‐group trial, the study enrolled 96 IDA patients who were randomly allocated (1:1) to receive a 500 mg intravenous dose of either the T or R preparation. Post‐dose blood samples for pharmacokinetic analysis were collected at multiple time points, while any adverse events were documented. The pharmacokinetic results showed comparable serum concentration‐time curves between the two groups. The 90% confidence intervals for the geometric mean ratios of C max , AUC 0− t , and AUC 0−∞ of total serum iron and C max , AUC 0− t of serum transferrin‐bound iron were within the predefined bioequivalence criterion of 80%–125%, indicating bioequivalence between the T and R preparations under fasting conditions. There were no significant differences in the safety profile between the two groups. This study confirmed the bioequivalence of the T and R preparations under fasting conditions, along with good safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MaltoseAnemia, Iron-DeficiencyFerric CompoundsHematinicsHumansMaleTherapeutic EquivalencyFemaleAdultFastingMiddle AgedYoung AdultArea Under CurveIronChinaInjections, IntravenousEast Asian People

Stichwörter der Autor:innen

bioequivalencebiosimilarferric carboxymaltose injectioniron deficiency anemiapharmacokinetics

Substanzen

ferric carboxymaltoseMaltoseFerric CompoundsIronHematinics

Autor:innen und Institutionen

  • Phase I Clinical Trial, Laboratory, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Co…
  • BrightGene Bio-Medical Technology Co., Ltd., Suzhou, China.
  • Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Shengling Hu

Zitieren

APA

Gong, F., Hu, S., Yuan, J., & Song, J. (2025). A Randomized, Open‐Label, Single‐Dose, Parallel‐Group Bioequivalence Study of Ferric Carboxymaltose Injection Under Fasting Conditions in Chinese Adult Subjects With Iron Deficiency Anemia. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70137

Vancouver

Gong F, Hu S, Yuan J, Song J. A Randomized, Open‐Label, Single‐Dose, Parallel‐Group Bioequivalence Study of Ferric Carboxymaltose Injection Under Fasting Conditions in Chinese Adult Subjects With Iron Deficiency Anemia. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70137

BibTeX
@article{Gong2025,
  author = {Gong, Fengyun and Hu, Shengling and Yuan, Jiandong and Song, Jianxin},
  title = {A Randomized, Open‐Label, Single‐Dose, Parallel‐Group Bioequivalence Study of Ferric Carboxymaltose Injection Under Fasting Conditions in Chinese Adult Subjects With Iron Deficiency Anemia},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70137}
}
Kostenlos starten →